🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
0.5650
-0.0488 (-7.95%)
At close: Nov 20, 2026, 4:00 PM EST
0.6000
+0.0350 (6.19%)
After-hours: Nov 20, 2026, 5:03 PM EST

Metagenomi Therapeutics Market Cap

Metagenomi Therapeutics has a market cap or net worth of $21.36 million as of November 20, 2026. It is the 35,848th most valuable company in the world and the 5,043rd biggest in the United States. Its market cap has decreased by 64.66% in one year.

Market Cap
21.36M
Enterprise Value
-44.10M
1-Year Change
-64.66%
Global Rank
Country Rank
#5,043 United States
Category

Chart

Chart

Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $21.36M, a decrease of -96.21%. That is a compound annual growth rate of -69.16%.

History

DateMarket Cap% Change
Nov 20, 202621.36M-64.88%
Dec 31, 202560.83M-54.98%
Dec 31, 2024135.10M-76.00%
Feb 9, 2024 (IPO)562.92M-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
CEL-SCI25.86M
Immutep25.58M
Lite Strategy24.99M
Polyrizon24.69M
GridAI Technologies24.43M
LeonaBio23.18M
ABVC BioPharma23.10M
TransCode Therapeutics22.50M
Market Cap Rankings